Skip to Content

BL Corp 142760 Stock Quote

| Rating as of

Morningstar‘s Stock Analysis 142760

Valuation
Currency in KRW
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Key Statistics 142760

Company Profile 142760

Business Description

BL Corp, formerly Bioleaders Corp engages in the biomedicine and biomaterial business in South Korea. It develops cervical intraepithelial dysplasia treatment which is in phase 3 clinical-stage; cervical cancer treatment which is in phase 2b clinical stage; and non-clinical vaccine adjuvant and treatment for muscular dystrophy.

Contact
767, Sinsu-Ro, 7th Floor, Suji-gu
Yongin-Si, 305-500, Korea, Republic of
T +82 429347671
Industry Biotechnology
Most Recent Earnings Jun 30, 2022
Fiscal Year End Dec 31, 2022
Employees 43